- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms in Ireland
Total 2637 results
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
GP-PharmCompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Advaxis, Inc.Merck Sharp & Dohme LLCCompleted
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingProstate CancerUnited States
-
AgennixTerminatedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
UNICANCERSanofi; European Organisation for Research and Treatment of Cancer - EORTC; I... and other collaboratorsActive, not recruitingMetastatic Prostate CancerFrance, Ireland, Spain, Switzerland, Belgium, Italy, Romania
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom, Netherlands, Ireland, Greece, France, Belgium, Denmark, Norway, Italy, Slovakia, Switzerland, Portugal, Finland, Hungary, Germany
-
Active Biotech ABCompleted
-
Brown UniversityTerminatedMelanoma | Prostate Cancer | Renal CancerUnited States
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
DendreonCompletedProstate CancerUnited States, Canada
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Boston Scientific CorporationRecruitingProstate CancerAustralia, Spain, United States, United Kingdom, Germany, Ireland, France, Italy, Switzerland
-
Hoffmann-La RocheActive, not recruitingMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, Argentina, Italy, Mexico, Spain, United Kingdom, Netherlands, Australia, Colombia, Belgium, Austria, Denmark, Puerto Rico, France, Israel, Peru, Romania, Russian Federation, Hungary, Brazil, Germany, Czech Republic, C... and more
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
AstraZenecaRecruitingProstate CancerUnited States, Spain, United Kingdom, Netherlands, Canada, Australia
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States, Guam
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
VA Office of Research and DevelopmentNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...Completed
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Myrexis Inc.UnknownProstate CancerUnited States
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsActive, not recruitingProstate CancerUnited States, Canada
-
Royal Marsden NHS Foundation TrustThe Institute of Cancer Research, Sutton, Surrey, UKActive, not recruitingProstate CancerNew Zealand, Ireland, United Kingdom, Canada